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Abstract The intrinsic fluorescence mission spectrum of elongation factor EF-2 due to the 7 Trp residues was not modified after complete 
phosphorylation of the factor by the specific Caz’/Cahnodulin-dependent kinase III. The effect of nucleotide binding on this fluorescence revealed 
differences between phosphorylated and unmodified EF-2. Low concentrations of GTP had a smaller quenching effect on the fluorescence of 
phosphorylated EF-2 than on the fluorescence of unmodified EF-2, whereas GDP had exactly the same quenching effect on the fluorescence of both 
samples. These results suggest hat phosphorylation of EF-2 decreased its affinity for GTP but not for GDP. Ability of phosphorylated EF-2 to form 
a ternary complex with ribosomes in the presence of a non-hydrolysable GTP analog and its ability to protect ribosomes against ricin-inactivation 
were both decreased to the same extent. The lower affinity of phosphorylated EF-2 for GTP could be responsible for a weaker and/or incorrect 
interaction of the factor with the ribosome, in particular with the ricin-site of the 28-S rRNA assumed to be involved in translocation initiation. 
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1. Introduction 
Elongation factor EF-2, like other translation factors, be- 
longs to the superfamily of proteins which are activated by 
GTP. It catalyses, like its counterpart in prokaryotic cells EF- 
G, the translocation of the peptidyl tRNA from the A to the 
P site of ribosome, which is followed by the hydrolysis of GTP 
into GDP and Pi. We have recently shown that interaction of 
EF-2 with GTP (as well as with other nucleotides) could be 
studied by measuring the quenching of the intrinsic fluores- 
cence of the factor due to its 7 Trp residues, in the presence of 
nucleotides [l]. It was possible to demonstrate by this technique 
that GTP binding induces a conformational change of the EF-2 
molecule which unmasks a tryptophan residue. This residue, 
which was identified as TrpU1, is required for biological activity 
since its oxidation inactivates the factor [2]. Subsequent results 
[3] suggested that this residue could interact with the 28s RNA 
loop including the GAGA sequence which is the target of ricin 
and which is assumed to be involved in initiating the transloca- 
tion process [4]. 
It is now well established that EF-2 can be inactivated by 
phosphorylation by a specific kinase which is Ca”-cahnodulin 
dependent [5-71. Two Thr residues can be phosphorylated, 
ThrS6 first and then Th? [8]. The primary mechanism of this 
inactivation has not been clearly identified yet. It was suggested 
either that the mechanism of translocation itself was blocked 
[9], or that the affinity of EF-2 for ribosomes was reduced [lo]. 
The effect of phosphorylation on the interaction of EF-2 with 
GTP has not been studied directly. However, it has been shown 
that phosphorylated EF-2 behaves differently from unmodified 
EF-2 in cross-linking experiments with 32P-labeled guanylic nu- 
cleotides using irradiation at 254 nm [ 111. Since measurements 
of the intrinsic fluorescence represent a very sensitive method 
to study protein-nucleotide interactions, we used this method 
to compare the affinity of phosphorylated EF-2 for nucleotides 
with that of unmodified EF-2. We also tested the ability of 
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phosphorylated EF-2 to protect ribosomes against ricin, in 
order to see if this modification of the factor would alter its 
interaction with the GAGA-containing loop of the 28s rRNA. 
2. Materials aud methods 
2.1. Materials 
GTP and GDP were purchased from Boehringer, ATP from Pharma- 
cia, and the micro BCA protein assay reagent from Pierce. 
[8-‘H]GuoPP[NH]P (9.25 GBq/mmol) was obtained from Amersham. 
Okadaic acid was from Calbiochem. 
2.2. Preparations 
Rat liver eEF-2 (>95% pure) was purified as described previously 
[12]. Preparation of rat liver ribosomes has also been described [13]. 
Purified ricin A-chain was a gift from Dr. Cazellas and purified EF-la 
was a gift from Dr. Crechet. EF-2 specific calcium-and calmodulin- 
dependent protein kinase III was prepared as described by Nygard et 
al. [14]. Protein concentration was determined with the Micro BCA 
protein assay [15]. 
2.3. Phosphorylation of eEF-2 
eEF-2 was phosphorylated by incubation in 20 mM HEPES- KOH 
pH 7.6, 10 mM MgC&, 0.15 mM CaCl,, 4.8pM CaM, 0.27pM okadaic 
acid, 125 PM ATP, containing 5 pmol eEF-2 and 2 pmol purified 
kinase. The reaction mixtures, 25 ~1, were incubated at 37’C for 60 min. 
The reaction was stopped by addition of 0.25,umol EGTA. Under these 
conditions, 100% of eEF-2 was phosphorylated as shown by isoelectro- 
focalisation. Phosphorylated eEF-2 was separated from the kinase 
using a FPLC system (Millipore) fitted with a MonoQ column (Phar- 
macia). The EF-2 sample and the column were equilibrated with 20 mM 
Tris-HCl, pH 7.6,0.1 mM EDTA, 1 mM DTT, 10% glycerol containing 
50 mM KCI. The proteins were eluted with a linear 50-500 mM KC1 
gradient. Phosphorylated eEF-2 was eluted at 200 mM KC1 and the 
kinase at 400 mM KCl. Fig. 1 shows the isofocalisation pattern of 
purified phosphorylated and unmodified eEF-2. This phosphorylated 
form should correspond to the phosphorylation of both ThrS6 and Thr5* 
residues. Indeed, when the incubation time was reduced, an additional 
band was observed with a migration intermediate between those of the 
two bands represented in Fig. 1. 
2.4. Treatment of ribosomes with ricin A-Chain 
Ribosomes were treated with ricin A-chain under conditions adapted 
from Brigotti et al. [16]. Briefly, rat liver ribosomes (10 pmol) were 
pre-incubated 15 min at 25°C in 45 ~1 in 80 mM Tris-HCl (pH 7.4), 
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120 mM KCl, 
GTP and 31.5 
7 mM MgCl,, 2 mM dithiothreitol containing 45 nmol 
pmol of native or phosphorylated eEF-2. Ricin-A chain 
was then added in 5 ~1 of buffer A to a final concentration of 0.15 nM 
and ribosomes were incubated for an additional 5 min at 25°C. Finally, 
10 ~1 were withdrawn from the reaction mixture for protein synthesis 
analysis. 
2.5. Activity measurements 
Poly-(U)-directed polyphenylalanine synthesis was measured as de- 
scribed previously [17] in the presence of 6 pmol of eEF-2 and 80 pmol 
of EF-la. These conditions designed to test the activity of ribosomes 
corresponded to an excess of EF-2. Formation of the ribosome-eEF-2- 
[8-3H]GuoPP[NH]P complex was measured [18] in the presence of 10 
pmol of ribosomes, increasing amounts of EF-2 phosphorylated or not 
and 20 ,uM [8-‘H]GuoPP[NH]P in a final volume of 100 ~1. 
2.6. Fluorescence measurements 
Emission fluorescence spectra of native or phosphorylated protein 
were recorded at 25.0 i: 0.1 “C on a SLM 8000 C spectra-fluorometer 
equipped with a 450 W Xenon lamp. The cuvette contained 1 ml of 0.08 
PM EF-2 in buffer A (20 mM Tris-HCl, pH 7.6,8 mM MgCl,, 100 mM 
KCl, 100 mM sucrose, 1 mM DTT and 10% glycerol). Excitation 
wavelength was 295 nm. Emission and excitation band-path was set at 
4 nm to ensure that only Trp residues were excited [19]. Variations of 
the lamp emission power were automatically corrected with a rhodam- 
ine solution used as a standard in the reference channel. Emission 
spectra were corrected for buffer blank. eEF-2 fluorescence quenching 
was deduced from the decrease of fluorescence intensity at 332 nm in 
the presence of increasing amounts of nucleotides [l] after correction 
for nucleotide inner-effect determined under the same conditions used 
with bovine serum albumin and N-acetyltryptophanamide [20]. 
3. Results 
3.1. Interaction ofphosphorylated EF-2 with nucleotides tudied 
by the quenching of its intrinsic fluorescence 
The fluorescence mission spectrum of phosphorylated EF- 
2, using an excitation wavelength of 295 nm, was found to be 
superposable with that of unmodified EF-2 (Fig. 2). This 
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Fig. 1. Isoelectrofocalisation of phosphorylated eEF-2. 1 ,ug of either 
phosphorylated or unmodified eEF-2 was analyzed with a PhastSystem 
(Pharmacia) using a 5-8 pH gradient. 
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Fig. 2. Fluorescence mission spectrum of phosphorylated eEF-2. This 
spectrum was determined in buffer A as indicated in section 2. Excita- 
tion wavelength was 295 nm. Phosphorylated eEF-2, continuous line; 
unmodified eEF-2. dashed line. 
fluorescence is due to the 7 Trp residues of the molecule [l]. 
Fluorescence was partly quenched after addition of increasing 
concentrations of GTP. However, for the low nucleotide con- 
centrations, the quenching observed with phosphorylated EF-2 
was significantly less than that observed with control EF-2. 
Data represented in Fig. 3A indicate that the apparent affinity 
of phosphorylated EF-2 for GTP deduced from the quenching 
values was reduced by a factor of 3.7 (I& = 44 PM instead of 
12 PM). On the other hand, the quenching value at saturation 
was slightly higher with phosphorylated EF-2 than with control 
(22% instead of 15%). Addition of increasing concentrations of 
GDP to phosphorylated and unmodified EF-2 produced identi- 
cal quenching (Fig. 3B). Since we had shown that ATP also 
partly quenched EF-2 fluorescence [l], we tested the effect of 
this nucleotide on the fluorescence of phosphorylated EF-2. 
Fig. 4 shows that with modified EF-2, higher concentrations of 
nucleotide were required to induce the same quenching. Satura- 
tion curves were sigmoidal, as already observed with native 
EF-2 [l]. 
3.2. Interaction of phosphorylated EF-2 with ribosomes and 
protection of them against ricin A 
The ability of phosphorylated EF-2 to form a complex with 
ribosomes was measured in the presence of [3H]Guo PP(NH)P, 
a radioactive derivative of GTP which is not hydrolyzed. As can 
be seen in Fig. 5A, there is a significant decrease of its ability 
to form the complex, as compared with that of 
unphosphorylated EF-2. The decrease corresponds to an affin- 
ity reduction of more than 4 fold (I& value of 0.14 ,uM instead 
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Fig. 3. Effect of guanylic nucleotides on the intrinsic fluorescence of 
phosphorylated EF-2. Phosphorylated (m) and non-phosphorylated (0) 
eEF-2 were incubated inbuffer A in the presence ofincreasing concen- 
trations of GTP (A) or GDP (B). Measurements were carried out as 
described in section 2. The reciprocal of the fluorescence d crease AF 
is plotted versus the reciprocal of the nucleotide concentration. I  this 
figure as in the two following ones each point represents he mean of 
the results obtained in 3 experiments. Standard eviation is indicated 
by bars when exceeding the width of the points. 
of 0.03 PM). This result is at least qualitatively in agreement 
with results obtained by Carlberg et al., using a different tech- 
nique: centrifugation through a sucrose gradient of mixtures 
containing ‘251-labeled EF-2 (phosphorylated or not), Guo 
PP(NH)P and a mixture of 40s and 60s subunits [lo]. It is well 
established that the toxin ricin inactivates the ribosome by 
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Fig. 4. Effect of ATP on the intrinsic fluorescence of phosphorylated 
EF-2. The fluorescence decrease of phosphorylated (m) and 
Fig. 5. Effect of EF-2 phosphorylation on ternary complex formation 
unphosphorylated (0)EF-2 is plotted as a function of increasing con- 
and on ribosome protection against kin. A: Plot of the reciprocal of 
centrations of ATP. The saturation curve is fitted to the Hill equation 
the concentration of the ternary complex formed versus the reciprocal 
of the native (0) or phosphorylated (B) eEF-2 concentration. Reaction 
which can be formulated : AF= AF,,,,,[S]“I(K’+[S]“) using the Multifit 
2.0 program (Day Computing, Cambridge, UK). AFis the fluorescence 
was performed as described in section 2. B: Plot of the reciprocal of the 
decrease of EF-2 in the presence of ATP [S] represents the nucleotide 
ribosome concentration protected against ricin inactivation versus the 
concentration, n is the Hill coefficient and x” a constant. 
reciprocal of the native (0) or phosphorylated (m) EF-2 concentration. 
Treatment of ribosomes is described in section 2. 
specific depurination of the A,,,, nucleotide in the 28-S rRNA 
[21]. We concluded from previous results that an EF-2 amino- 
acid sequence containing Trp**’ can protect the ribosome 
against ricin inactivation [3]. Therefore it was interesting to 
investigate whether phosphorylated EF-2 could prevent ribo- 
some inactivation by ricin. Indeed, the decreased affinity of the 
modified factor for ribosome could affect the presumed interac- 
tion between Trp**’ and the GAGA target of Ricin, and this 
could account for the total inactivity of phosphorylated EF-2. 
Fig. 5B shows that protection of ribosomes against ricin was 
lower with phosphorylated EF-2 than with unmodified EF-2. 
This decrease paralleled that of phosphorylated-EF-2 affinity 
for ribosomes, the Kd values determined in both cases being 
almost identical (0.16 and 0.14 ,uM, respectively, instead of 0.03 
,uM for unmodified EF-2). 
4. Discussion 
Our present study confirms that phosphorylated EF-2 has a 
decreased ability to form a ternary complex with ribosomes and 
a non-hydrolyzable GTP analog. But in addition, using the very 
sensitive technique of intrinsic fluorescence measurements, our 
results suggest that even in the absence of ribosomes, 
phosphorylated EF-2 has a decreased affinity for GTP, but not 
for GDP. The possibility that EF-2 phosphorylation did not 
affect GTP binding but rather modified the Trp fluorescence 
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in such a way that this fluorescence was less quenched by the 
nucleotide was ruled out, since the emission spectra of 
phosphorylated and unmodified EF-2 were identical. The 
phosphorylated amino-acid residues (Thr56 Thti’) do not be- 
long to the consensus equences which are supposed to interact 
with GTP [22]. Therefore the reduced affinity of 
phosphorylated EF-2 for GTP is probably due to differences 
in the conformation of the factor. Activation of EF-2 with GTP 
is most likely the prerequisite step for its binding to ribosomes. 
An impaired complex formation between phosphorylated EF-2 
and GTP should result in a decreased afIinity of the modified 
factor for the ribosome and, consequently, for the ricin site of 
28s rRNA assumed to be involved in triggering the transloca- 
tion process [4]. The fact that the apparent K,, values found for 
the different interactions of phosphorylated EF-2 showed a 
similar increase supports the hypothesis that these variations 
result from the same cause. However it is not clear whether such 
an increase (by a factor of 4) can account entirely for the almost 
total inhibition of protein synthesis observed in the presence of 
phosphorylated EF-2. It should be noted that, reciprocally, 
EF-2 cannot be phosphorylated when included in a ternary 
complex with a GTP analog and ribosome, whereas it is fully 
reactive when included in a complex with GDP and ribosome 
[13]. Comparison of the effect of EF-2 phosphorylation with 
that of the other EF-2 post-translational modification, ADP- 
ribosylation, is interesting, because in the latter case there is 
also a decrease in the affinity of EF-2 for ribosome in the 
presence of a GTP analog but no modification of the interac- 
tion of EF-2 with GTP (Sontag et al., unpublished results). The 
significance of the decreased affinity of phosphorylated EF-2 
for ATP is not clear, since the meaning of the interaction of 
unmodified EF-2 with this nucleotide remains unknown yet. 
We do not know, in particular, wether the interaction site of 
guanylic and adenylic nucleotides with EF-2 are different or 
not. However, the fact that phosphorylation of EF-2 affects the 
interaction of the factor with both nucleosides tri-phosphate 
(but not di-phosphate) suggests a common site of interaction 
for the y-phosphate of guanylic and adenylic nucleotides. 
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